Reducing Disparities in the Quality of Advance Care Planning for Older Adults
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Metastatic Cancer
Related studies linked through entity extraction aliases.
Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
A Dose-escalation Trial of Stereotactic Ablative Body Radiotherapy for Non-spine Bone & Lymph Node Oligometastates
- Status
- COMPLETED
- Phase
- NA
Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
European iNvestigation of SUrveillance After Resection for Esophageal Cancer
- Status
- COMPLETED
- Phase
- N/A
Investigation of the Timely-coordinated Therapy of Patients With Metastatic Cancer by Radiotherapy Together With Immune Checkpoint Inhibition
- Status
- COMPLETED
- Phase
- N/A
A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of ASN007 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers of Immune-Related Toxicity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.
- Status
- UNKNOWN
- Phase
- N/A
RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6
- Status
- COMPLETED
- Phase
- PHASE2
Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors
- Status
- TERMINATED
- Phase
- PHASE1